Position in ABBV
as of Jun 30, 2026
· filed Jul 9, 2026
Position Value
$3,420,794
+$288,069 QoQ
Shares Held
13,594
-5.6% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.51%
of 13F equity value
Holder Rank
#1,562
of 4,150 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Gilman Hill Asset Management, LLC holds $40,633,070 across 8 Drug Manufacturers - General names. ABBV ranks #4 (8.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BMY |
Bristol Myers Squibb Co
|
231,255 | $13,324,913 | |
| 2 | PFE |
Pfizer Inc
|
428,237 | $10,311,946 | |
| 3 | GSK |
GSK plc
|
128,768 | $6,750,018 | |
| 4 | ABBV |
AbbVie Inc.
This page
|
13,594 | $3,420,794 | |
| 5 | JNJ |
Johnson & Johnson
|
12,793 | $3,249,038 | |
| 6 | LLY |
ELI LILLY & Co
|
1,606 | $1,926,284 | |
| 7 | MRK |
Merck & Co., Inc.
|
10,457 | $1,343,724 | |
| 8 | AMGN |
Amgen Inc
|
846 | $306,353 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,420,794 | 13,594 | Shares | Sole | 2026-07-09 | |
| 2026-03-31 | $3,132,725 | 14,404 | Shares | Sole | 2026-04-08 | |
| 2025-12-31 | $3,262,608 | 14,279 | Shares | Sole | 2026-01-12 | |
| 2025-09-30 | $3,206,365 | 13,848 | Shares | Sole | 2025-10-15 | |
| 2025-06-30 | $2,461,692 | 13,262 | Shares | Sole | 2025-07-09 | |
| 2025-03-31 | $2,917,566 | 13,925 | Shares | Sole | 2025-04-10 | |
| 2024-12-31 | $2,475,361 | 13,930 | Shares | Sole | 2025-01-16 | |
| 2024-09-30 | $2,750,896 | 13,930 | Shares | Sole | 2024-10-10 | |
| 2024-06-30 | $2,433,011 | 14,185 | Shares | Sole | 2024-07-12 | |
| 2024-03-31 | $2,886,102 | 15,849 | Shares | Sole | 2024-04-12 | |
| 2023-12-31 | $2,534,379 | 16,354 | Shares | Sole | 2024-01-10 | |
| 2023-09-30 | $2,454,123 | 16,464 | Shares | Sole | 2023-10-13 | |
| 2023-06-30 | $2,218,464 | 16,466 | Shares | Sole | 2023-07-14 | |
| 2023-03-31 | $2,692,715 | 16,896 | Shares | Sole | 2023-04-20 | |
| 2022-12-31 | $13,068,431 | 80,864 | Shares | Sole | 2023-01-20 | |
| 2022-09-30 | $10,917,580 | 81,347 | Shares | Sole | 2022-10-21 | |
| 2022-06-30 | $12,210,221 | 79,722 | Shares | Sole | 2022-07-15 | |
| 2022-03-31 | $10,322,840 | 63,678 | Shares | Sole | 2022-04-14 | |
| 2021-12-31 | $13,164,942 | 97,230 | Shares | Sole | 2022-01-18 | |
| 2021-09-30 | $10,670,392 | 98,919 | Shares | Sole | 2021-10-13 | |
| 2021-06-30 | $10,498,949 | 93,208 | Shares | Sole | 2021-07-16 | |
| 2021-03-31 | $10,184,800 | 94,112 | Shares | Sole | 2021-04-19 | |
| 2020-12-31 | $9,196,577 | 85,829 | Shares | Sole | 2021-01-19 | |
| 2020-09-30 | $7,695,657 | 87,860 | Shares | Sole | 2020-10-16 | |
| 2020-06-30 | $8,595,855 | 87,552 | Shares | Sole | 2020-07-20 | |
| 2020-03-31 | $6,910,585 | 90,702 | Shares | Sole | 2020-04-22 | |
| No filing history on record for this holder in this stock. | ||||||